Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001493152-24-042327
Filing Date
2024-10-24
Accepted
2024-10-24 09:38:14
Documents
2

Document Format Files

Seq Description Document Type Size
1 form424b5.htm 424B5 446240
2 form424b5_001.jpg GRAPHIC 24131
  Complete submission text file 0001493152-24-042327.txt   480768
Mailing Address 4475 EXECUTIVE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 4475 EXECUTIVE DRIVE SUITE 200 SAN DIEGO CA 92121 858-794-9600
Calidi Biotherapeutics, Inc. (Filer) CIK: 0001855485 (see all company filings)

EIN.: 862967193 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-282456 | Film No.: 241390965
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)